4/27/2021I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulc...

4/27/2021BioPlan: Chinese CDMO Sector Growing but Unlikely To Make Global Impac...

4/27/2021Simcere Pharma Ditches Cell Therapy to Focus on Oncology

4/26/2021SMEI: Review of Chinese Terminal Drug Markets in 2011 - 2020

4/23/2021Hua Medicine Files Chinese NDA for Dorzagliatin

4/23/2021China and Mexico Sign Regulatory Cooperation Agreement for Medical Pro...

4/23/2021Recent Executive Moves

4/22/2021CDE Issues the Two Technical Guidelines for Clinical Trial of Pertuzum...

4/22/2021NMPA Issues 2020 Drug Regulatory Statistics Annual Report

4/22/2021State Council Introduces New Policy to Establish/Enhance Employee BMI ...

4/20/2021Citrine Med and Sinopharm Enter Partnership to Enhance Access to Rare ...

4/20/2021AffaMed Therapeutics and SIFI Announce Joint Venture to Serve Greater ...

4/20/2021Top Ten Chemical Drugs and Brands in Major Chinese Urban Hospitals 202...

4/20/2021Review of Hospital Drug Market in Shanghai 2020

4/19/2021A Share-Listed Chinese MedPharm Cos Report Performance in 2020 and Q1/...

4/19/2021PhIRDA/RDPAC: Fostering China Pharmaceutical Innovation System Report ...

4/16/2021State Council Calls for Liberalization of Online Prescription Drug Sal...

4/16/2021PhIIC: Urban Chinese Hospital Drug Sales Down 13% in 2020 Due to Pande...

4/16/2021Biogen's Tecfidera Approved in China for Relapsing Multiple Sclerosis

4/16/2021Sinopharm to Inject $4.6 bln Vaccine Assets into Unit Tiantan Biologic...

4/16/2021Recent Executive Moves

4/15/2021Kintor and Visum Announced Strategic Partnership to Expand Proxalutami...

4/15/2021Lonza to Make Junshi Biosciences Antibody at China Facility

4/15/2021Latest Update on the Upcoming 5th Round of VBP

4/15/2021China Issues the 2021 Work Highlights of the Healthy China Initiative

4/15/2021Numerous Local Champions and MNCs Among the 19 Pharma Cos Fined by the...

4/14/2021Chinese MOF Fines 19 Pharma Companies for Inflating Drug Prices

4/14/2021AZ's Tagrisso Approved in China as Adjuvant Treatment for Early EGFRm ...

4/14/2021Denovo's Licenses DB102 (Enzastaurin) for Rare Genetic Pediatric Onset...

4/14/2021Simcere's Marketing Application for First-to-copy Ibrutinib Accepted b...

Page:95/360 Total number of articles:10791: [First][<<] [93] [94] [95] [96] [97] [>>] [End]